Gametocyte Carriage, Antimalarial Use, and Drug Resistance in Cambodia, 2008-2014.

Gametocytes are the malaria parasite stages responsible for transmission from humans to mosquitoes. Gametocytemia often follows drug treatment, especially as therapies start to fail. We examined Plasmodium falciparum gametocyte carriage and drug resistance profiles among 824 persons with uncomplicated malaria in Cambodia to determine whether prevalent drug resistance and antimalarial use has led to a concentration of drug-resistant parasites among gametocyte carriers. Although report of prior antimalarial use increased from 2008 to 2014, the prevalence of study participants presenting with microscopic gametocyte carriage declined. Gametocytemia was more common in those reporting antimalarial use within the past year, and prior antimalarial use was correlated with higher IC50s to piperaquine and mefloquine, as well as to increased pfmdr1 copy number. However, there was no association between microscopic gametocyte carriage and parasite drug resistance. Thus, we found no evidence that the infectious reservoir, marked by those carrying gametocytes, is enriched with drug-resistant parasites.

[1]  Jonathan J. Juliano,et al.  Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia , 2017, Genome biology and evolution.

[2]  D. Fidock,et al.  A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study , 2017, The Lancet. Infectious diseases.

[3]  D. Kwiatkowski,et al.  Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study. , 2017, The Lancet. Infectious diseases.

[4]  Philip Smith,et al.  Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand , 2016, Malaria Journal.

[5]  Teun Bousema,et al.  Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data , 2016, BMC Medicine.

[6]  S. Meshnick,et al.  Microscopic Plasmodium falciparum Gametocytemia and Infectivity to Mosquitoes in Cambodia. , 2016, The Journal of infectious diseases.

[7]  S. Meshnick,et al.  Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. , 2015, The Lancet. Infectious diseases.

[8]  S. Tyner,et al.  Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance , 2015, Antimicrobial Agents and Chemotherapy.

[9]  Saorin Kim,et al.  Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment , 2015, Antimicrobial Agents and Chemotherapy.

[10]  R. Maude,et al.  Spatial and temporal epidemiology of clinical malaria in Cambodia 2004–2013 , 2014, Malaria Journal.

[11]  D. Kwiatkowski,et al.  Spread of artemisinin resistance in Plasmodium falciparum malaria. , 2014, The New England journal of medicine.

[12]  B. Genton,et al.  A molecular marker of artemisinin-resistant Plasmodium falciparum malaria , 2013, Nature.

[13]  Andrew F. Read,et al.  Enhanced Transmission of Drug-Resistant Parasites to Mosquitoes following Drug Treatment in Rodent Malaria , 2012, PloS one.

[14]  S. Meshnick,et al.  Plasmodium falciparum Gametocyte Carriage Is Associated with Subsequent Plasmodium vivax Relapse after Treatment , 2011, PloS one.

[15]  Teun Bousema,et al.  Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and Elimination , 2011, Clinical Microbiology Reviews.

[16]  S. Meshnick,et al.  Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia , 2009, Malaria Journal.

[17]  D. Socheat,et al.  Counterfeit and substandard antimalarial drugs in Cambodia. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[18]  R. Price,et al.  Risk factors for gametocyte carriage in uncomplicated falciparum malaria. , 1999, The American journal of tropical medicine and hygiene.

[19]  R. Price,et al.  Effects of artemisinin derivatives on malaria transmissibility , 1996, The Lancet.